Cargando…
Accelerating target discovery using pre-competitive open science—patients need faster innovation more than anyone else
We are experiencing a new era enabled by unencumbered access to high quality data through the emergence of open science initiatives in the historically challenging area of early stage drug discovery. At the same time, many patient-centric organisations are taking matters into their own hands by part...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Cancer Intelligence
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4990051/ https://www.ncbi.nlm.nih.gov/pubmed/27594912 http://dx.doi.org/10.3332/ecancer.2016.ed57 |